These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7108224)

  • 1. Isolation and characterization of a monoclonal antibody-resistant antigenic mutant of Toxoplasma gondii.
    Kasper LH; Crabb JH; Pfefferkorn ER
    J Immunol; 1982 Oct; 129(4):1694-9. PubMed ID: 7108224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies.
    Kasper LH; Bradley MS; Pfefferkorn ER
    J Immunol; 1984 Jan; 132(1):443-9. PubMed ID: 6197455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii.
    Kasper LH
    Parasite Immunol; 1987 Jul; 9(4):433-45. PubMed ID: 3627825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody.
    Kasper LH; Crabb JH; Pfefferkorn ER
    J Immunol; 1983 May; 130(5):2407-12. PubMed ID: 6833761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30).
    Mineo JR; Kasper LH
    Exp Parasitol; 1994 Aug; 79(1):11-20. PubMed ID: 8050521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of membrane antigens of Toxoplasma gondii.
    Handman E; Goding JW; Remington JS
    J Immunol; 1980 Jun; 124(6):2578-83. PubMed ID: 7373040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic similarity between Hammondia hammondi and Toxoplasma gondii tachyzoites.
    Riahi H; Bouteille B; Darde ML
    J Parasitol; 1998 Jun; 84(3):651-3. PubMed ID: 9645881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production and characterization of a panel of monoclonal antibodies to Toxoplasma gondii antigens].
    Poryvaeva VA; Aborneva IV; Bormotov NI; Gladkova SE; Reshetnikov SS; Kuvshinova IN; Rukavishnikov MIu; Dedkova LM; Belanov EF
    Mol Gen Mikrobiol Virusol; 2003; (4):20-4. PubMed ID: 14664158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein.
    Hoe LN; Wan KL; Nathan S
    Parasitology; 2005 Dec; 131(Pt 6):759-68. PubMed ID: 16336729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the specificities of monoclonal and polyclonal antibodies to Neospora, Toxoplasma and Cryptosporidium by fluorescent antibody test (FAT).
    Latif BM; Jakubek EB
    Trop Biomed; 2008 Dec; 25(3):225-31. PubMed ID: 19287361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody].
    Fachado A; Fernández N; Hernández E; Fonseca L
    Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: stable complementation of sag1 (p30) mutants using SAG1 transfection and fluorescence-activated cell sorting.
    Kim K; Boothroyd JC
    Exp Parasitol; 1995 Feb; 80(1):46-53. PubMed ID: 7821410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA antibodies to Toxoplasma gondii in human tears.
    Meek B; Klaren VN; van Haeringen NJ; Kijlstra A; Peek R
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2584-90. PubMed ID: 10937570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
    Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
    J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii: characterization of a mutant resistant to 6-thioxanthine.
    Pfefferkorn ER; Borotz SE
    Exp Parasitol; 1994 Nov; 79(3):374-82. PubMed ID: 7957757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii.
    Pfefferkorn ER; Pfefferkorn LC
    J Parasitol; 1978 Jun; 64(3):486-92. PubMed ID: 207846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of invasion and multiplication of Toxoplasma gondii in human colonic epithelial cells by a monoclonal antibody against protein SAG2].
    Osorio JC; Sánchez RM; Iraola RC; Pérez JS
    Rev Cubana Med Trop; 2001; 53(3):161-9. PubMed ID: 15846919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BSR4 protein is up-regulated in Toxoplasma gondii bradyzoites, however the dominant surface antigen recognised by the P36 monoclonal antibody is SRS9.
    Van TT; Kim SK; Camps M; Boothroyd JC; Knoll LJ
    Int J Parasitol; 2007 Jul; 37(8-9):877-85. PubMed ID: 17368655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.